[The role of antimicrobial stewardship programs in the control of bacterial resistance].
In order to improve infection prognosis and reduce the existing microbial resistance problem (a challenge similar to that of climate change), a higher implication of the Administration, an increased level of social awareness and the development of specific corporate networks, including the pharmaceutical industry, is needed. However, we must first consolidate Antimicrobial Stewardship Programmes with experts who seek to improve antibiotic therapy effectivity in severe infections and to reduce global antibiotic exposure.
Juan Pasquau, Unidad de Enfermedades Infecciosas. Hospital Virgen de las Nieves. Complejo Hospitalario Universitario de Granada, Spain. jpasquau@gmail.com.
J
J
Pasquau
S
S
Sadyrbaeva
S E
SE
De Jesús
C
C
Hidalgo-Tenorio
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006801:Humans; D057970:Inappropriate Prescribing / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents